Bioinformatics

At Alithea, our approach to bioinformatics is deeply rooted in continuous innovation and refinement, supported by our unique and expanding immunopeptidomic data collection. This extensive and growing dataset is a cornerstone of our work, enabling us to develop and enhance tools specifically designed to support T cell and antibody therapy development.

Our in-house development of bioinformatics tools is a robust, ongoing process, driven by the real-world data we gather and the insights we gain from diverse projects. This continuous refinement allows us to adapt our models to better address the complex challenges faced by researchers and clinicians in the field of immunotherapy.

Each tool is not only grounded in reliable and expansive data but also evolves as we incorporate new information, ensuring it remains effective and relevant over time. By maintaining a strong focus on the robustness and continuity of our improvement process, Alithea provides bioinformatics solutions that are specifically tailored to advance T cell and antibody therapies. This commitment ensures that our clients have access to the most advanced, precise, and up-to-date tools in the industry, supporting high-impact research and therapeutic development.